Histatin for Corneal Wound Healing and Ocular Surface Disease
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- VISUS THERAPEUTICS INC
- Publication Date
- 2013-11-21
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
REFERENCE TO RELATED APPLICATIONS
[0001] This application claims one or more inventions which were disclosed in Provisional Application No. 61 / 648,845, filed May 18, 2012, entitled “HISTATIN FOR CORNEAL WOUND HEALING AND OCULAR SURFACE DISEASE”. The benefit under 35 USC §119(e) of the United States provisional application is hereby claimed, and the aforementioned application is hereby incorporated herein by reference.BACKGROUND OF THE INVENTION
[0002] 1. Field of the Invention
[0003] The invention pertains to the field of wound and disease healing. More particularly, the invention pertains to corneal wound healing and treating ocular surface disease using histatins.
[0004] 2. Description of Related Art
[0005] Histatins have been shown in in vitro studies to be wound healing agents from saliva. More specifically, WO 2009 / 087117 (and its US equivalent US Patent Publication 2011 / 0178010), herein incorporated by reference, identified peptides of histatin, which had wound healing properties in vit...